kaleidoscope
Επιφανές μέλος
Η kaleidoscope αυτή τη στιγμή δεν είναι συνδεδεμένη. Επαγγέλεται Φοιτητής/τρια και μας γράφει απο Θεσσαλονίκη (Θεσσαλονίκη). Έχει γράψει 9,248 μηνύματα.
17-05-11
21:55
Νεογνολόγο;
Σημείωση: Το μήνυμα αυτό γράφτηκε 13 χρόνια πριν. Ο συντάκτης του πιθανόν να έχει αλλάξει απόψεις έκτοτε.
kaleidoscope
Επιφανές μέλος
Η kaleidoscope αυτή τη στιγμή δεν είναι συνδεδεμένη. Επαγγέλεται Φοιτητής/τρια και μας γράφει απο Θεσσαλονίκη (Θεσσαλονίκη). Έχει γράψει 9,248 μηνύματα.
03-05-11
00:31
δεν χρειαζεσαι γυναικολογο για να διαγνωσεις καρκινο του μαστου.
και δεν λεω πουθενα οτι δεν χρειαζεται να τσεκαρεις μια στο τοσο, αυτο που ειπα εξ αρχης ειναι οτι οι γυναικολογοι βγαζουν τα περισοτερα λεφτα απο ολους τους υπολοιπους γιατρους γιατι...αγνωστο γιατι, γιατι υπαρχει ο μυθος οτι ΚΑΘΕ γυναικα πρεπει να πηγαινει μια φορα το εξαμηνο στο γυναικολογο, και οτι η πρωτη επισκεψη σε γυναικολογο πρεπει να γινει οταν γινει σεξουαλικα ενεργη και ειναι αυτο σημαδιακο.
μην του δινετε τοση σημασια γιατι δεν εχει.
Ρίξε μια ματιά εδώ.
Σημείωση: Το μήνυμα αυτό γράφτηκε 13 χρόνια πριν. Ο συντάκτης του πιθανόν να έχει αλλάξει απόψεις έκτοτε.
kaleidoscope
Επιφανές μέλος
Η kaleidoscope αυτή τη στιγμή δεν είναι συνδεδεμένη. Επαγγέλεται Φοιτητής/τρια και μας γράφει απο Θεσσαλονίκη (Θεσσαλονίκη). Έχει γράψει 9,248 μηνύματα.
02-05-11
20:20
Χαλαρα, ο γυναικολογος ειναι οπως ολοι οι αλλοι γιατροι, μια στο τοσο ενα τσεκ απ κανει καλο, αλλα μην μας πιανει και πανικος.
ειναι απειρος πιο πιθανο να παθει οστεοποροση/καρδια/αθηροσκληροση/διαβητη/καρκινο του παχεως εντερου και οτι αλλο βαλει ο νους σου απο καρκινο της μητρας/τραχιλου (thats prety much it).
τεσπα οι γυναικολογικοι καρκινοι (δεν βαζω τον καρκινο του μαστου σαν γυναικολογικο καρκινο, και αντρες τον παθαινουν και δεν θελεις γυναικολογο για να σε ψαχνει - οχι απαραιτητα) ειναι 5 στη λιστα με τους πιο συχνους καρκινους στις γυναικες και δεν ειναι καν στην δεκαδα για ολους τους ανθρωπους.
Δεν είναι μόνο ο καρκίνος που μας απασχολεί, όπως είπαμε και παραπάνω:
Δεν είναι μόνο ο καρκίνος του τραχήλου της μήτρας που μας απασχολεί.
Καλό είναι να ξέρεις τι γίνεται πάνω κάτω με τα γεννητικά σου όργανα και την αναπαραγωγική σου υγεία γενικότερα, όπως επίσης και να είσαι ενημερωμένη για μεθόδους αντισύλληψης.
Σοβαρά; Δεν τον βάζεις στους γυναικολογικούς καρκίνους επειδή και άνδρες μπορεί να αναπτύξουν καρκίνο στο στήθος;
In the US, approximately 207,090 new cases of female invasive breast cancer were predicted to occur in 2010, along with 1,970 cases in men .
Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. Sep-Oct 2010;60(5):277-300.
Στα υπόλοιπα συμφωνώ με την Myrtle.
Σημείωση: Το μήνυμα αυτό γράφτηκε 13 χρόνια πριν. Ο συντάκτης του πιθανόν να έχει αλλάξει απόψεις έκτοτε.
kaleidoscope
Επιφανές μέλος
Η kaleidoscope αυτή τη στιγμή δεν είναι συνδεδεμένη. Επαγγέλεται Φοιτητής/τρια και μας γράφει απο Θεσσαλονίκη (Θεσσαλονίκη). Έχει γράψει 9,248 μηνύματα.
30-04-11
00:33
Εγώ πάω ακόμα στην παιδίατρο μου ότι πρόβλημα υγείας και να έχω.
Εγώ ρωτάω την παιδίατρο μου για τα εμβόλια. Και αν χρειαστεί να κάνω κανένα επαναληπτικό πάω σε αυτήν.
δεν πρεπει να το αμελει ειναι πολυ βασικο να κανει καθε 6 μηνες αντε 1 φορα τον χρονο στην χειροτερη ΤΕΣΤ ΠΑΠ
[...]
και εγω φωναζω στην δικια μου, βαριεται να κλεισει ραντεβου και το καθυστερει αντι για 6 μηνες πηγαινει στον χρονο....ντροπη
6 μήνες; Πρώτη φορά το ακούω αυτό. Ποιος σου είπε για τόσο συχνά τεστ ΠΑΠ;
American Cancer Society Guidelines for the Early Detection of Cancer
Cervical cancer
All women should begin cervical cancer screening about 3 years after they begin having vaginal intercourse, but no later than 21 years old. Screening should be done every year with the regular Pap test or every 2 years using the newer liquid-based Pap test.
Beginning at age 30, women who have had 3 normal Pap test results in a row may get screened every 2 to 3 years. Women older than 30 may also get screened every 3 years with either the conventional or liquid-based Pap test, plus the human papilloma virus (HPV) test.
Women 70 years of age or older who have had 3 or more normal Pap tests in a row and no abnormal Pap test results in the last 10 years may choose to stop having Pap tests.
Women who have had a total hysterectomy (removal of the uterus and cervix) may also choose to stop having Pap tests, unless the surgery was done as a treatment for cervical cancer or pre-cancer. Women who have had a hysterectomy without removal of the cervix should continue to have Pap tests.
Some women -- because of their history -- may need to have a different screening schedule for cervical cancer.
All women should begin cervical cancer screening about 3 years after they begin having vaginal intercourse, but no later than 21 years old. Screening should be done every year with the regular Pap test or every 2 years using the newer liquid-based Pap test.
Beginning at age 30, women who have had 3 normal Pap test results in a row may get screened every 2 to 3 years. Women older than 30 may also get screened every 3 years with either the conventional or liquid-based Pap test, plus the human papilloma virus (HPV) test.
Women 70 years of age or older who have had 3 or more normal Pap tests in a row and no abnormal Pap test results in the last 10 years may choose to stop having Pap tests.
Women who have had a total hysterectomy (removal of the uterus and cervix) may also choose to stop having Pap tests, unless the surgery was done as a treatment for cervical cancer or pre-cancer. Women who have had a hysterectomy without removal of the cervix should continue to have Pap tests.
Some women -- because of their history -- may need to have a different screening schedule for cervical cancer.
American College of Obstetricians and Gynecologists
Revised Guidelines (November 2009)
Specific ACOG recommendations in the updated guidelines, based on good and consistent scientific evidence (level A), are as follows:
Cervical cancer screening should begin at age 21 years and should be avoided at younger ages, when it may result in unnecessary and harmful workup and treatment in women who are at very low risk for cancer.
For women aged 21 to 29 years, cervical cytology screening is recommended every 2 years.
The interval between cervical cytology examinations may be extended to every 3 years for women at least aged 30 years who have had 3 consecutive negative cervical cytology screening test results and who have no history of CIN 2 or CIN 3, HIV infection, immunocompromised state, or DES exposure in utero.
Acceptable screening techniques are liquid-based and conventional cervical cytology methods.
Routine cytology testing should be discontinued in women who have had a total hysterectomy for benign conditions and who have no history of high-grade CIN.
For women older than 30 years, an appropriate screening test is cytology combined with HPV DNA testing. When both these test results are negative in a low-risk woman 30 years or older, rescreening should be performed no sooner than 3 years later.
Specific ACOG recommendations in the updated guidelines, based on limited and inconsistent scientific evidence (level B), are as follows:
Sexually active women younger than 21 years should be counselled and tested for sexually transmitted infections and should be counselled regarding safe sex and contraception. Cervical cytology testing is not necessary, and speculum examination need not be performed in asymptomatic women.
Cervical cancer screening can be discontinued between the ages of 65 and 70 years in women who have 3 or more consecutive negative cytology test results and no abnormal test results in the past 10 years because cervical cancer develops slowly, and risk factors decrease with age.
Women previously treated for CIN 2, CIN 3, or cancer remain at risk for persistent or recurrent disease for at least 20 years after treatment and after initial posttreatment surveillance. This group should therefore continue to be screened annually for at least 20 years.
Even after the period of posttreatment surveillance, screening should continue for women status post hysterectomy with removal of the cervix who have a history of CIN 2 or CIN 3, or in whom a negative history cannot be documented. In this patient group, there are no good data to support or refute discontinuing screening.
Revised ACOG recommendations, based primarily on consensus and expert opinion (level C), are as follows:
Physicians should inform their patients that annual gynecologic examinations may still be appropriate regardless of the frequency of cervical cytology screening, even if cervical screening is not performed at each visit.
Women who were vaccinated against HPV-16 and HPV-18 should follow the same screening guidelines as nonvaccinated women.
Specific ACOG recommendations in the updated guidelines, based on good and consistent scientific evidence (level A), are as follows:
Cervical cancer screening should begin at age 21 years and should be avoided at younger ages, when it may result in unnecessary and harmful workup and treatment in women who are at very low risk for cancer.
For women aged 21 to 29 years, cervical cytology screening is recommended every 2 years.
The interval between cervical cytology examinations may be extended to every 3 years for women at least aged 30 years who have had 3 consecutive negative cervical cytology screening test results and who have no history of CIN 2 or CIN 3, HIV infection, immunocompromised state, or DES exposure in utero.
Acceptable screening techniques are liquid-based and conventional cervical cytology methods.
Routine cytology testing should be discontinued in women who have had a total hysterectomy for benign conditions and who have no history of high-grade CIN.
For women older than 30 years, an appropriate screening test is cytology combined with HPV DNA testing. When both these test results are negative in a low-risk woman 30 years or older, rescreening should be performed no sooner than 3 years later.
Specific ACOG recommendations in the updated guidelines, based on limited and inconsistent scientific evidence (level B), are as follows:
Sexually active women younger than 21 years should be counselled and tested for sexually transmitted infections and should be counselled regarding safe sex and contraception. Cervical cytology testing is not necessary, and speculum examination need not be performed in asymptomatic women.
Cervical cancer screening can be discontinued between the ages of 65 and 70 years in women who have 3 or more consecutive negative cytology test results and no abnormal test results in the past 10 years because cervical cancer develops slowly, and risk factors decrease with age.
Women previously treated for CIN 2, CIN 3, or cancer remain at risk for persistent or recurrent disease for at least 20 years after treatment and after initial posttreatment surveillance. This group should therefore continue to be screened annually for at least 20 years.
Even after the period of posttreatment surveillance, screening should continue for women status post hysterectomy with removal of the cervix who have a history of CIN 2 or CIN 3, or in whom a negative history cannot be documented. In this patient group, there are no good data to support or refute discontinuing screening.
Revised ACOG recommendations, based primarily on consensus and expert opinion (level C), are as follows:
Physicians should inform their patients that annual gynecologic examinations may still be appropriate regardless of the frequency of cervical cytology screening, even if cervical screening is not performed at each visit.
Women who were vaccinated against HPV-16 and HPV-18 should follow the same screening guidelines as nonvaccinated women.
Σημείωση: Το μήνυμα αυτό γράφτηκε 13 χρόνια πριν. Ο συντάκτης του πιθανόν να έχει αλλάξει απόψεις έκτοτε.
kaleidoscope
Επιφανές μέλος
Η kaleidoscope αυτή τη στιγμή δεν είναι συνδεδεμένη. Επαγγέλεται Φοιτητής/τρια και μας γράφει απο Θεσσαλονίκη (Θεσσαλονίκη). Έχει γράψει 9,248 μηνύματα.
29-04-11
22:02
Δηλαδή μία κοπέλα πρέπει να επισκεφτεί έναν γυναικολόγο μετά τα 18 ακόμη και αν δεν έχει ολοκληρωμένη σεξουαλική σχέση; Ποιός ο λόγος; Αφού όπως λέει η MissKit 'ο κίνδυνος εμφάνισης καρκίνου του τραχήλου είναι πολύ μικρός πριν τα 21'
Δεν είναι μόνο ο καρκίνος του τραχήλου της μήτρας που μας απασχολεί.
Καλό είναι να ξέρεις τι γίνεται πάνω κάτω με τα γεννητικά σου όργανα και την αναπαραγωγική σου υγεία γενικότερα, όπως επίσης και να είσαι ενημερωμένη για μεθόδους αντισύλληψης.
Σημείωση: Το μήνυμα αυτό γράφτηκε 13 χρόνια πριν. Ο συντάκτης του πιθανόν να έχει αλλάξει απόψεις έκτοτε.